Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Amortization of Deferred Charges (2017 - 2020)

Historic Amortization of Deferred Charges for Forte Biosciences (FBRX) over the last 4 years, with Q1 2020 value amounting to $654000.0.

  • Forte Biosciences' Amortization of Deferred Charges rose 36056.34% to $654000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $2.2 million, marking a year-over-year increase of 9117.65%. This contributed to the annual value of $1.7 million for FY2019, which is 4625.32% up from last year.
  • Per Forte Biosciences' latest filing, its Amortization of Deferred Charges stood at $654000.0 for Q1 2020, which was up 36056.34% from $57000.0 recorded in Q4 2019.
  • Forte Biosciences' 5-year Amortization of Deferred Charges high stood at $1.4 million for Q3 2019, and its period low was $57000.0 during Q4 2019.
  • In the last 4 years, Forte Biosciences' Amortization of Deferred Charges had a median value of $147000.0 in 2017 and averaged $315615.4.
  • Within the past 5 years, the most significant YoY rise in Forte Biosciences' Amortization of Deferred Charges was 84755.24% (2019), while the steepest drop was 8016.53% (2019).
  • Quarter analysis of 4 years shows Forte Biosciences' Amortization of Deferred Charges stood at $149000.0 in 2017, then fell by 2.68% to $145000.0 in 2018, then tumbled by 60.69% to $57000.0 in 2019, then surged by 1047.37% to $654000.0 in 2020.
  • Its last three reported values are $654000.0 in Q1 2020, $57000.0 for Q4 2019, and $1.4 million during Q3 2019.